Donor cells | Trial 1 | Trial 2 | Trial 3 | Trial 4 | Ave ± Std |
---|
ICs/ml* | ICs/ml | ICs/ml | ICs/ml | ICs/ml | Relative infectivity** |
---|
293T/XMRV/pcDNA3 | 7.0 X 104 | l.3 X l05 | l.5 X 105 | 1.5 X 105 | l.2 ± 0.37 X l05 | 1 ± 0 |
293T/XMRV/hA3B | 8.5 X 104 | l.0 X l05 | l.4 X l05 | l.2 X l05 | 1.1 ± 0.23 X l05 | 0.931 ± 0.185 |
293T/MX/pcDNA3 | 8.4 X 105 | 1.4 X 106 | 3.2 X 106 | 3.3 X 106 | 2.2 ± 1.2 X 106 | 16.7 ± 5.91 |
293T/MX/hA3B | 1.0 X 106 | l.9 X 106 | 4.1 X 106 | 3.3 X 106 | 2.6 ± 1.4 X 106 | 19.8 ± 6.22 |
- The infected 293 T cells were transfected with the plasmid encoding HA-tagged hA3B plasmids (293 T/XMRV/hA3B and 239 T/MX/hA3B) or control plasmids (293 T/XMRV/pcDNA3 and 293 T/MX/pcDNA3). HeLa cells were infected with XMRV released from the viral producing cells described above. *The infectious units (IU) were measured from the number of infectious centers that was normalized by the amount of Capsid in viruses and IU per ml was shown. **The relative infectivity to the HeLa cells infected with the virus released from 293 T/XMRV/pcDNA cells was shown.